GSK Showers Shareholders With Cash
GlaxoSmithKline (NYSE: GSK) , the U.K.'s largest pharmaceutical company, has released its second-quarter results. Thanks to rising earnings and dividends, its shares remain attractively priced, particularly to income-seeking investors.
GSK goes for growthGSK reported second-quarter sales down 2% to 6.7 billion pounds. However, after stripping out sales of pandemic-related products, diabetes drugAvandiaand herpes medicationValtrex, underlying sales growth rose by 5%.... Read more
GSK
Latest Price: $ 55.15
Dividend Yield (TTM): 3.19%
- 2025-05-16: $ 0.43
- 2025-08-15: $ 0.43
- 2025-11-14: $ 0.42
- 2026-02-20: $ 0.49
Source: Yahoo Finance. Stock prices and dividends can be delayed, cached or incomplete.
Older articles featuring GSK:
International Quality Dividend Growth - 2020 ReconstitutionDividend Income Summary: Bert's October 2020 Summary
Dividend Income Update October 2020
47 Dividend Stocks For Our Changing Times: November Update
Ex-Dividend Dates For The Upcoming Week And One Company I Wouldn't Buy
71 Announced Dividend Boosts November 2
The 33 Dividend Stocks Fit For Our Times October Update
33 Dividend Stocks Fit For COVID-19 Times: A September Update
112 Equities Hiked Dividends In August (Against 32 Reductions) And 35 Signaled Buys
33 Fit Dividend Stocks For Our Times: The August Assortment